4 stories found
Callan JMB Inc. and Glucotrack have both announced that they have regained compliance with Nasdaq's listing requirements. Callan JMB met the minimum bid price requirement, while Glucotrack satisfied the equity requirement.
GlucoTrack reported a narrowing of its net loss for the first quarter. The financial improvement was highlighted in a report on TradingView.
Glucotrack has finalized its business combination with Lōkahi Therapeutics, creating a new AI-driven healthcare platform.
BT Brands reported a GAAP EPS of -$0.12 and revenue of $2.84 million. Glucotrack also released its first-quarter financial results.